NEWS
CSL Seqirus Canada News Releases
2024
CSL Seqirus Canada News Releases
2024
FLUAD® Adjuvanted Flu Vaccines for Quebec Seniors Aged 65 and Older: CSL Seqirus Welcomes the Comité sur l’Immunisation du Québec (CIQ)’s Recommendation
FLUAD® Influenza vaccine (surface antigen, inactivated, adjuvanted with MF59®) is now preferentially recommended by the Comité sur l’immunisation du Québec (Quebec Immunization Committee, or CIQ) for adults 65 years of age and older.
CSL Seqirus, a Proud Champion of Pandemic Preparedness, Announces U.S. Government Award in Response to Avian Influenza
· CSL Seqirus to complete the fill and finish process for pre-pandemic vaccine to support the U.S. government’s outbreak and preparedness response.
· Outbreaks of highly pathogenic avian influenza (HPAI) viruses in birds and livestock have been reported in the U.S.
· Fourth avian influenza pandemic preparedness award to CSL Seqirus under a multi-year agreement with Biomedical Advanced Research and Development Authority (BARDA).